Type I receptor serine-threonine kinase preferentially expressed in pulmonary blood vessels

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 270, Issue 4 14-4, 1996, Pages

  Panchenko, Mikhail P ^a   Williams, Mary C ^a   Brody, Jerome S ^a   Yu, Qiang ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

endothelium; lung development; smooth muscle; transforming growth factor

Indexed keywords

PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL TISSUE; ARTICLE; CELL SELECTION; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; IN SITU HYBRIDIZATION; LUNG DEVELOPMENT; LUNG ENDOTHELIUM; NONHUMAN; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE; TISSUE DISTRIBUTION;

EID: 0029942635     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1996.270.4.l547     Document Type: Article

References (55)

1. Attisano, L, J. Carcamo, F. Ventura, F. M. B. Weis, J. Massague, and J. L. Wrana. Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75: 671-681, 1993.
2. Attisano, L, J. L. Wrana, S. Cheifetz, and J. Massague. Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors. Cell 68: 97-108, 1992.
3. Augustin, H. G., D. H. Kozian, and R. C. Johnson. Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes. BioEssays 16: 901-906, 1994.
4. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. Preparation and analysis of RNA. In: Current Protocols in Molecular Biology. New York: Wiley, 1991, p. 4.2.1.-4.2.8.
5. Bassing, C. H., D. J. Howe, P. R. Segarini, P. K. Donahoe, and X.-F. Wang. A single heteromeric receptor complex is sufficient to mediate biological effects of transforming growth factor-β ligands. J. Biol. Chem. 269: 14861-14864, 1994.
6. Bassing, C. H., J. M. Yingling, D. J. Howe, T. Wang, W. W. He, M. L. Gustafson, P. Shah, P. K. Donahoe, and X.-F. Wang. A transforming growth factor β type I receptor that signals to activate gene expression. Science Wash. DC 263: 87-89, 1994.
7. Brody, J. S., and W. M. Thurlbeck. Development, growth, and aging of the lung. In: Handbook of Physiology. The Respiratory System. Mechanics of Breathing. Bethesda, MD: Am. Physiol. Soc., 1986, sect. 3, vol. III, part 1, chapt. 22, p. 355-386.
8. Carcamo, J., F. M. B. Weis, F. Ventura, R. Weiser, J. L. Wrana, L. Attisano, and J. Massague. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor β and activin. Mol. Cell Biol. 14: 3810-3821, 1994.
9. Catlin, E. A., S. M. Powell, T. F. Manganaro, P. L. Hudson, R. C. Ragin, J. Epstein, and P. K. Donahoe. Sex-specific fetal lung development and Müllerian inhibiting substance. Am. Rev. Respir. Dis. 141: 466-470, 1990.
10. Ebner, R., R.-H. Chen, S. Lawler, T. Zioncheck, and R. Derynck. Determination of type I receptor specificity by the type II receptors for TGF-β or activin. Science Wash. DC 262: 900-902, 1993.
11. Ebner, R., R.-H. Chen, L. Shum, S. Lawler, T. F. Zioncheck, A. Lee, A. R. Lopez, and R. Derynck. Cloning of a type I TGF-β receptor and its effect on TGF-β binding to the type II receptor. Science Wash. DC 260: 1344-1348, 1993.
12. Feijen, A., M. J. Goumans, and A. J. M. van den Eijndenvan Raaij. Expression of activin subunits, activin receptors and follistatin in postimplantation mouse embryos suggests specific developmental functions for different activins. Development 120: 3621-3637, 1994.
13. Fine, A., and R. H. Goldstein. The effect of transforming growth factor-β on cell proliferation and collagen formation by lung fibroblasts. J. Biol. Chem. 262: 3897-3902, 1987.
14. Franzen, P., P. ten Dijke, H. Ichijo, H. Yamashita, P. Schultz, C.-H. Heldin, and K. Miyazono. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell 75: 681-692, 1993.
15. Gerritsen, M. E., and C. M. Bloor. Endothelial cell gene expression in response to injury. FASEB J. 7: 523-532, 1993.
16. Hanks, S. K., A. M. Quinn, and T. Hunter. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science Wash. DC 241: 42-52, 1988.
17. He, W. H., M. L. Gustafson, S. Hirobe, and P. K. Donahoe. Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family. Dev. Dynamics 196: 133-142, 1993.
18. Heine, U. I., E. F. Munoz, K. C. Flanders, A. B. Roberts, and M B. Sporn. Colocalization of TGF-beta 1 and collagen I and III, fibronectin and glycosaminoglycans during lung branching morphogenesis. Development 109: 29-36, 1990.
19. Kingsley, D. M. The TGF-β superfamily new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8: 133-146, 1994.
20. Kozak, M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15: 8125-8148, 1987.
21. Kozak, M. An analysis of vertebrate mRNA sequences: intimations of translation control. J. Cell Biol. 115: 887-903, 1991.
22. Kraal, G., and M. Janse. Marginal metallophilic cells of the mouse spleen identified by a monoclonal antibody. Immunology 58: 665-699, 1986.
23. Kulkarni, A. B., C.-G. Huh, D. Becker, A. Geiser, M. Lyght, K. C. Flanders, A. B. Roberts, M. B. Sporn, J. M. Ward, and S. Karlsson. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90: 770-774, 1993.
24. Lin, H. Y., and H. F. Lodish. Receptors for the TGF-β superfamily: multiple polypeptides and serine/threonine kinase. Trends Cell Biol. 3: 14-19, 1993.
25. Lin, H. Y., X.-F. Wang, E. Ng-Eaton, R. A. Weinberg, and H. F. Lodish. Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68: 775-785, 1992.
26. Massague, J. Receptors for the TGF-β family. Cell 69: 1067-1070, 1992.
27. Massague, J. The transforming growth factors. Trends Biochem. Sci. 10: 237-240, 1985.
28. Masui, T., L. M. Wakefield, J. F. Lechner, M. LaVeck, M. B. Sporn, and C. C. Harris. Type β transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc. Natl. Acad. Sci. USA 83: 2438-2442, 1986.
29. Mathews, L. S., and W. W. Vale. Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 65: 973-982, 1991.
30. Matsuzaki, K., J. Xu, F. Wang, W. L. McKeehan, L. Krummen, and M. A. Kan. Widely expressed transmembrane serine/ threonine kinase that does not bind activin, inhibin, transforming growth factor b, or bone morphogenic factor. J. Biol. Chem. 268: 12719-12723, 1993.
31. McCarthy, S. A., and R. Bicknell. Inhibition of vascular endothelial cell growth by activin-A. J. Biol. Chem. 268: 23066-23071, 1993.
32. McCarthy, S. A., I Kuzu, K. C. Gatter, and R. Bicknell. Heterogeneity of the endothelial cell and its role in organ preference of tumor metastasis. Trends Pharmacol. Sci. 12: 462-467, 1991.
33. McGowan, S. E., and R. McNamer. Transforming growth factor-β increases elastin production by neonatal rat lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 3: 369-376, 1990.
34. Moses, H. L., E. Y. Yang, and J. A, Pietenpol. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63: 245-247, 1990.
35. Nabel, E. G., L. Shum, V. J. Pompili, Z.-Y. Yang, H. San, H. B. Shu, S. Liptay, L. Gold, D. Gordon, R. Derynk, and G. J. Nabel. Direct transfer of transforming growth factor β1 gene into arteries stimulates flbrocellular hyperplasia. Proc. Natl. Acad. Sci. USA 90: 10759-10763, 1993.
36. Pelton, R. W., M. D. Johnson, E. A. Perkett, L. I. Gold, and H. L. Moses. Expression of transforming growth factor-β1, β2, and β3 mRNA and protein in the murine lung. Am. J. Respir. Cell Mol. Biol. 5: 522-530, 1991.
37. Perkett, E. A., R. W. Pelton, B. Meyrick, L. I. Gold, and D. A. Miller. Expression of transforming growth factor-β mRNAs and proteins in pulmonary vascular remodeling in the sheep air embolization model of pulmonary hypertension. Am. J. Respir. Cell Mol. Biol. 11: 16-24, 1994.
38. RayChaudhury, A., and P. A. D'Amore. Endothelial cell regulation by transforming growth factor-beta. J. Cell. Biochem. 47: 224-229, 1991.
39. Rishi, A. K., M. Joyce-Brady, J. Fisher, L. G. Dobbs, J. Floro, J. VanderSpek, J. S. Brody, and M. C. Williams Cloning, characterization, and developmental expression of a rat lung alveolar type I cell gene in embryonic endodermal and neural derivatives. Dev. Biology 167: 294-306, 1995.
40. Roberts, A. B., M. A. Anazano, M Lalage, N. S. Wakefield, D. F. Roche, and M. B. Sporn. Type β transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA 82: 119-123, 1985.
41. Roberts, A. B., and M. B. Sporn. The transforming growth factor-βs. In: Peptide Growth Factors and Their Receptors, edited by M. B. Sporn and A. B. Roberts. New York: Springer-Verlag, 1991, vol. 1, p. 419-472.
42. Ryan, U. S., J. W. Ryan, C. Whitaker, and A. Chiu. Localization of angiotensin converting enzyme (kinase II). II. Immunocytochemistry and immunofluorescence. Tissue Cell 8: 125-146, 1976.
43. Sachs, A. B. Messenger RNA degradation in eukariots. Cell 74: 413-421, 1993.
44. Sambrook, J., E. F. Fritsch, and T. Maniatis. Extraction, purification, and analysis of messenger RNA from eukaryotic cells. In: Molecular Cloning. A Laboratory Manual (2nd ed.). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989, vol. 1. p. 7.26-7.29.
45. Shaw, G., and R. Kamen. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNAmediates selective mRNA degradation. Cell 46: 659-667, 1986.
46. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlovsky, R. J. Diebold, M. Yin, R. Allen, C. Sidman, F. Proetzel, D. Calvin, N. Annunziata, and T. Doetschman. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature Lond. 359: 693-699, 1992.
47. ten Dijke, P., H. Ichijo, P. Franzen, P. Schulz, J. Saras, H. Toyoshima, C.-H. Heldin, and K. Miyazono. Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity. Oncogene 8: 2879-2887, 1993.
48. ten Dijke P., H. Yamashita, H. Ichijo, P. Franzen, M. Laiho, K. Miyazono, and C.-H. Heldin. Characterization of type I receptors for transforming growth factor-β and activin. Science Wash. DC 264: 101-104, 1994.
49. ten Dijke P., H. Yamashita, T. K. Sampath, A. H. Reddi, M. Estevez, D. L. Riddle, H. Ichijo, C.-H., Heldin, and K. Miyazono. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269: 16985-16987, 1994.
50. Tsuchida, K., K. A. Lewis, L. S. Mathews, and W. W. Vale. Molecular characterization of rat transforming growth factor-β type II receptor. Biochem. Biophys. Res. Commun. 191: 790-795, 1993.
51. Tsuchida, K., L. S. Mathews, and W. W. Vale. Cloning and characterization of a transmembrane serine kinase that acts as an activin type I receptor. Proc. Natl. Acad. Sci. USA 90: 11242-11246, 1993.
52. r=35,000 surfactant-associated protein in fetal lung. J. Biol. Chem. 262: 7908-7913, 1987.
53. Wrana, J. L., L. Attisano, J. Carcamo, A. Zentella, J. Doody, M. Laiho, X.-F. Wang, and J. Massague. TGFβ signals through a heteromeric protein kinase receptor complex. Cell 71: 1003-1014, 1992.
54. Wrana, J. L., L. Attisano, R. Weiser, F. Ventura, and J. Massague. Mechanism of activation of the TGF-β receptor. Nature Lond. 370: 341-347, 1994.
55. Yamashita, H., P. ten Dijke, P. Franzen, K. Miyazono, and C.-H. Heldin. Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-β. J. Biol Chem. 269: 20172-20178, 1994.